NCT07829796

Brief Summary

Cerebral palsy can affect walking ability, muscle control, functional mobility, and psychosocial well-being in children. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that may support motor learning, while virtual reality (VR) rehabilitation provides interactive, repetitive, and task-specific motor training. This randomized controlled trial will investigate whether active tDCS combined with VR rehabilitation provides additional benefits compared with sham tDCS combined with the same VR rehabilitation and conventional physical therapy in children with spastic cerebral palsy. A total of 42 children aged 8 to 16 years with spastic diplegic cerebral palsy and Gross Motor Function Classification System (GMFCS) levels I-III will be randomly assigned in a 1:1:1 ratio to one of three groups: active tDCS plus VR, sham tDCS plus VR, or conventional physical therapy. Each group will receive 18 treatment sessions over six weeks, with three sessions per week. Outcomes will be assessed before treatment, after nine sessions, and after 18 sessions. The primary outcomes will be gait performance measured using the 10-Meter Walk Test and self-esteem measured using the Rosenberg Self-Esteem Scale. Secondary outcomes will evaluate spasticity, gross motor function, functional mobility, and functional independence.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Sep 2026Oct 2026

First Submitted

Initial submission to the registry

September 15, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

September 15, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 21, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2026

Last Updated

September 23, 2026

Status Verified

September 1, 2026

Enrollment Period

1 month

First QC Date

September 15, 2026

Last Update Submit

September 20, 2026

Conditions

Keywords

Spastic Cerebral PalsySpastic DiplegiaTranscranial Direct Current StimulationVirtual RealityVR RehabilitationWalking SpeedMotor FunctionGross Motor Function

Outcome Measures

Primary Outcomes (2)

  • 10-Meter Walk Test Self-Selected Walking Velocity

    Gait performance will be assessed using the 10-Meter Walk Test at a self-selected walking pace. Walking velocity will be expressed in meters per second (m/s), with higher values indicating faster walking performance. The measure will be collected at baseline, mid-intervention, and post-intervention.

    Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  • Child Rosenberg Self-Esteem Scale Total Score

    Global self-esteem will be assessed using the Child Rosenberg Self-Esteem Scale. The scale contains 10 items and produces a total score ranging from 0 to 30, with higher scores indicating greater self-esteem. The total score will be assessed at baseline, mid-intervention, and post-intervention.

    Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

Secondary Outcomes (7)

  • Modified Tardieu Scale

    Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  • GMFM-88

    Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  • Functional Mobility Scale - 5 m, 50 m, and 500 m

    Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  • Pediatric Evaluation of Disability Inventory-Computer Adaptive Test Daily Activities Domain Scaled Score

    Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  • Pediatric Evaluation of Disability Inventory-Computer Adaptive Test Mobility Domain Scaled Score

    Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  • +2 more secondary outcomes

Study Arms (3)

Experimental: Active tDCS + Virtual Reality

EXPERIMENTAL

Participants will receive active transcranial direct current stimulation at 1 mA for 20 minutes combined with virtual reality rehabilitation, three sessions per week for six weeks, for a total of 18 sessions.

Device: Active Transcranial Direct Current StimulationBehavioral: Virtual Reality Rehabilitation

Sham Comparator: Sham tDCS + Virtual Reality

SHAM COMPARATOR

Participants will receive sham transcranial direct current stimulation using the same electrode setup, with brief initial stimulation to mimic active tDCS, combined with the same virtual reality rehabilitation protocol, three sessions per week for six weeks.

Device: Sham Transcranial Direct Current StimulationBehavioral: Virtual Reality Rehabilitation

Active Comparator: Conventional Physical Therapy

ACTIVE COMPARATOR

Participants will receive conventional physical therapy including stretching, strengthening, balance training, gait training, and functional mobility exercises, three sessions per week for six weeks.

Behavioral: Conventional Physical Therapy

Interventions

Active transcranial direct current stimulation will be delivered using saline-soaked sponge electrodes at an intensity of 1 mA for 20 minutes per session. Stimulation will be administered three times per week for six weeks, for a total of 18 sessions, concurrently with virtual reality rehabilitation. The stimulation montage will target the lower-limb motor cortical region with a supraorbital reference electrode.

Also known as: Active tDCS
Experimental: Active tDCS + Virtual Reality

Sham transcranial direct current stimulation will use the same electrode montage and setup as the active condition. Active current will be delivered only during the initial 30 seconds to reproduce the early sensory experience of stimulation, after which stimulation will be discontinued while the electrodes remain in place. Sham tDCS will be combined with the same virtual reality rehabilitation protocol as the active tDCS group.

Also known as: Sham tDCS
Sham Comparator: Sham tDCS + Virtual Reality

Virtual reality rehabilitation will be delivered using a Microsoft Xbox console with Kinect motion tracking. The program will include progressive whole-body, balance, gait-related, coordination, navigation, and dual-task activities using Kinect Adventures. Training will progress through familiarization, cognitive-motor integration, and challenge/functional integration phases over six weeks. VR will be provided in both the active and sham tDCS groups for 18 sessions.

Also known as: Xbox Kinect-Based Virtual Reality Therapy
Experimental: Active tDCS + Virtual RealitySham Comparator: Sham tDCS + Virtual Reality

Conventional physical therapy will be delivered for 30 minutes per session, three sessions per week for six weeks, for a total of 18 sessions. Treatment will progress from lower-limb stretching, supported balance and weight shifting to strengthening, motor-control exercises, gait initiation, overground gait training, obstacle negotiation, and functional mobility activities. Exercise difficulty and therapist support will be progressed according to participant tolerance and functional ability.

Also known as: CPT
Active Comparator: Conventional Physical Therapy

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosed with spastic cerebral palsy (spastic diplegia). Age 8-16 years. Gross Motor Function Classification System (GMFCS) levels I-III. Presence of mild to moderate lower-limb spasticity, defined as a Modified Tardieu Scale (MTS) score between 1 and 3 in at least one major lower-limb muscle group, such as the gastrocnemius, hamstrings, or hip adductors.
  • Able to understand and follow verbal instructions. Parent or guardian provides informed consent and the child provides assent.

You may not qualify if:

  • History of seizures or epilepsy. Implanted metal or electronic devices, such as a pacemaker. Severe cognitive impairment that prevents comprehension of study tasks. Skin allergies, lesions, or other conditions affecting the electrode application sites.
  • Current use of antispasticity medication that could directly influence spasticity outcomes.
  • Botulinum toxin injection within the previous 3 months. Recent orthopedic surgery or change in medication regimen within the previous 5 days.
  • Concurrent participation in alternative or adjunct therapies outside the study protocol.
  • Refusal to participate or withdrawal of consent/assent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Al-Farabi Special Education Centre for Physically Handicapped

Islamabad, 44000, Pakistan

RECRUITING

Sedum School of Rehabilitation

Islamabad, 44000, Pakistan

RECRUITING

Related Publications (4)

  • Jung S, Song S, Lee D, Lee K, Lee G. Effects of Kinect Video Game Training on Lower Extremity Motor Function, Balance, and Gait in Adolescents with Spastic Diplegia Cerebral Palsy: A Pilot Randomized Controlled Trial. Dev Neurorehabil. 2021 Apr;24(3):159-165. doi: 10.1080/17518423.2020.1819458. Epub 2020 Sep 27.

    PMID: 32981401BACKGROUND
  • Grecco LA, Duarte Nde A, de Mendonca ME, Pasini H, Lima VL, Franco RC, de Oliveira LV, de Carvalho Pde T, Correa JC, Collange NZ, Sampaio LM, Galli M, Fregni F, Oliveira CS. Effect of transcranial direct current stimulation combined with gait and mobility training on functionality in children with cerebral palsy: study protocol for a double-blind randomized controlled clinical trial. BMC Pediatr. 2013 Oct 11;13:168. doi: 10.1186/1471-2431-13-168.

    PMID: 24112817BACKGROUND
  • Lazzari RD, Politti F, Belina SF, Collange Grecco LA, Santos CA, Dumont AJL, Lopes JBP, Cimolin V, Galli M, Santos Oliveira C. Effect of Transcranial Direct Current Stimulation Combined With Virtual Reality Training on Balance in Children With Cerebral Palsy: A Randomized, Controlled, Double-Blind, Clinical Trial. J Mot Behav. 2017 May-Jun;49(3):329-336. doi: 10.1080/00222895.2016.1204266. Epub 2016 Sep 20.

    PMID: 27644454BACKGROUND
  • Collange Grecco LA, de Almeida Carvalho Duarte N, Mendonca ME, Galli M, Fregni F, Oliveira CS. Effects of anodal transcranial direct current stimulation combined with virtual reality for improving gait in children with spastic diparetic cerebral palsy: a pilot, randomized, controlled, double-blind, clinical trial. Clin Rehabil. 2015 Dec;29(12):1212-23. doi: 10.1177/0269215514566997. Epub 2015 Jan 20.

    PMID: 25604912BACKGROUND

MeSH Terms

Conditions

Cerebral Palsy

Interventions

2-cyclohexylidenhydrazo-4-phenyl-thiazole

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • WAQAR AHMED AWAN, PROFESSOR

    RIPHAH INTERNATIONAL UNIVERSITY PAKISTAN

    STUDY CHAIR

Central Study Contacts

HASSAN R RAUF, MS PEDIATRIC PHYSICAL THERAPY

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessments will be performed by an assessor who is blinded to participant group allocation. Participants assigned to the active and sham tDCS groups will undergo the same electrode placement and virtual reality rehabilitation protocol. The sham condition will mimic the initial sensation of active stimulation; however, because the conventional physical therapy arm involves a visibly different intervention, participant masking will not apply across all three study groups
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1:1 ratio to one of three parallel intervention groups: active transcranial direct current stimulation combined with virtual reality rehabilitation, sham transcranial direct current stimulation combined with the same virtual reality rehabilitation, or conventional physical therapy. Each group will receive 18 treatment sessions over six weeks, with three sessions per week. Outcomes will be assessed at baseline, after nine sessions, and after 18 sessions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head OF Department

Study Record Dates

First Submitted

September 15, 2026

First Posted

September 21, 2026

Study Start

September 15, 2026

Primary Completion (Estimated)

October 28, 2026

Study Completion (Estimated)

October 28, 2026

Last Updated

September 23, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared publicly because the study involves a pediatric clinical population and the consent and ethical approval were not designed for unrestricted external sharing of participant-level data. Aggregate and de-identified study results will be reported in the thesis and subsequent publications.

Locations